Iradimed Co

IRMD · NASDAQ · Healthcare / Medical Devices

85.35USD+0.12 (+0.14%)

Price History

Full chart

Market Stats

Previous Close85.23

Open85.19

Day Range84.29 – 86.17

52-Week Range67.74 – 107.20

Volume115.21K

Market Cap1.10B

P/E (TTM)47.91

Forward P/E41.15

EPS1.79

Dividend Yield0.93%

Beta0.90

50-Day Avg88.57

200-Day Avg93.99

About

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.

Company Details

SectorHealthcare
IndustryMedical Devices
CEOMr. Roger E. Susi
Employees166
Headquarters12705 Ingenuity Drive, Orlando, FL, United States, 32826, USA
Websitehttps://www.iradimed.com

Leadership

Mr. Roger E. SusiFounder, Chairman, CEO & President · b. 1953
Mr. John F. GlennCFO & Corporate Secretary · b. 1962
Mr. Jeff ChiprinChief Commercial Officer · b. 1966
Mr. Randy WaddellVice President of Worldwide Sales & Marketing
Mr. Chris WilliamsonExecutive Vice President of Continuous Improvement & Information Technology
Mr. Matt GarnerController
Mr. Lynn NeuhardtVice President of Research & Development

Financials

Income Statement

Currency: USD	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	7.69M	11.34M	15.65M	31.59M	32.50M	23.08M	30.44M	38.52M	31.72M	41.81M	53.30M	65.56M	73.24M	83.81M
Growth (%)	-	+47.56%	+38.03%	+101.84%	+2.86%	-28.97%	+31.88%	+26.54%	-17.65%	+31.83%	+27.48%	+23.00%	+11.71%	+14.43%
Cost of Revenue	2.13M	2.85M	3.40M	5.84M	6.15M	5.57M	7.21M	8.82M	8.14M	9.76M	12.02M	15.40M	16.89M	19.49M
Gross Profit	5.56M	8.49M	12.25M	25.75M	26.34M	17.51M	23.23M	29.70M	23.57M	32.05M	41.28M	50.16M	56.35M	64.32M
Gross Margin	72.34%	74.84%	78.25%	81.51%	81.06%	75.87%	76.31%	77.11%	74.33%	76.65%	77.45%	76.50%	76.94%	76.75%
Operating Expense	4.13M	5.70M	9.18M	14.24M	15.42M	16.23M	17.22M	21.05M	24.33M	22.23M	25.65M	30.12M	34.39M	38.18M
Operating Income	1.42M	2.79M	3.07M	11.51M	10.92M	1.29M	6.00M	8.65M	-756.09K	9.82M	15.63M	20.04M	21.96M	26.15M
Operating Margin	18.54%	24.58%	19.59%	36.44%	33.60%	5.57%	19.72%	22.45%	-2.38%	23.48%	29.32%	30.56%	29.99%	31.20%
EBITDA	1.53M	2.93M	3.21M	11.51M	11.17M	2.59M	7.11M	9.89M	582.73K	11.24M	16.30M	20.04M	25.09M	30.74M
EBITDA Margin	19.92%	25.80%	20.54%	36.44%	34.37%	11.24%	23.35%	25.68%	1.84%	26.89%	30.58%	30.56%	34.26%	36.68%
Net Income	966.09K	1.94M	2.05M	7.53M	7.21M	499.76K	6.30M	9.63M	1.37M	9.33M	12.83M	17.19M	19.23M	22.48M
Net Income Margin	12.57%	17.08%	13.10%	23.83%	22.20%	2.17%	20.71%	25.00%	4.32%	22.30%	24.06%	26.22%	26.26%	26.82%
R&D	654.07K	1.01M	1.07M	1.76M	1.35M	1.72M	1.52M	1.43M	1.90M	1.91M	2.28M	2.86M	2.83M	2.98M
R&D as % of Total Revenue	8.51%	8.91%	6.83%	5.58%	4.15%	7.46%	4.98%	3.72%	6.00%	4.56%	4.27%	4.36%	3.87%	3.55%
Interest Expense	0	0	0	0	0	0	0	395.91K	139.21K	18.61K	581.85K	-	-	-
Interest Expense % of Total Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.03%	0.44%	0.04%	1.09%	-	-	-

Balance Sheet

Currency: USD	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	5.55M	6.99M	23.31M	35.24M	37.19M	39.01M	48.44M	66.73M	71.07M	82.88M	85.51M	92.16M	98.33M	108.78M
Total Liabilities	2.33M	1.56M	2.42M	3.31M	5.31M	6.08M	6.50M	11.20M	9.68M	10.71M	11.84M	20.74M	11.51M	14.16M
Total Equity	3.22M	5.42M	20.89M	31.93M	31.89M	32.93M	41.95M	55.52M	61.38M	72.17M	73.67M	71.42M	86.82M	94.62M
Cash	1.70M	2.46M	9.45M	19.37M	17.71M	18.21M	28.03M	43.48M	50.07M	62.00M	57.96M	49.76M	52.23M	51.16M
Total Debt	519.73K	6.33K	-	-	-	-	-	2.96M	2.72M	2.48M	2.21M	2.04M	154.69K	-
Net Debt	-1.18M	-2.46M	-9.45M	-19.37M	-17.71M	-18.21M	-28.03M	-40.53M	-47.35M	-59.52M	-55.76M	-47.72M	-52.08M	-51.16M

Cash Flow

Currency: USD	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	1.51M	1.47M	2.59M	7.65M	9.41M	3.42M	7.38M	10.23M	5.82M	11.26M	10.04M	13.47M	25.62M	24.95M
Investing Cash Flow	-166.27K	-196.75K	-8.30M	-61.47K	-1.94M	-1.02M	1.52M	3.20M	246.97K	648.24K	-1.37M	-8.01M	-8.82M	-8.42M
Financing Cash Flow	-238.53K	-513.40K	12.71M	2.33M	-9.12M	-1.90M	929.87K	2.02M	522.48K	24.43K	-12.71M	-13.66M	-14.34M	-17.60M
Capital Expenditure	161.56K	191.76K	606.29K	314.84K	1.52M	824.76K	264.67K	485.81K	636.75K	741.76K	1.87M	8.01M	8.01M	7.76M
Free Cash Flow	1.35M	1.28M	1.98M	7.33M	7.88M	2.59M	7.11M	9.75M	5.18M	10.52M	8.17M	5.46M	17.62M	17.18M
Dividends Paid	-	-	0	0	0	0	-	12.56M	12.56M	12.56M	12.56M	13.22M	13.68M	15.04M
FCF to OCF	89.29%	86.99%	76.55%	95.88%	83.79%	75.86%	96.41%	95.25%	89.05%	93.41%	81.33%	40.53%	68.76%	68.87%
Dividend Paid to FCF	-	-	0.00%	0.00%	0.00%	0.00%	-	128.85%	242.42%	119.42%	153.77%	242.27%	77.63%	87.53%

Earnings

Report Date	Aug 12, 2014	Oct 30, 2014	Feb 5, 2015	Apr 30, 2015	Jul 30, 2015	Oct 30, 2015	Feb 5, 2016	Apr 29, 2016	Jul 29, 2016	Oct 28, 2016	Feb 6, 2017	Apr 28, 2017	Jul 28, 2017	Oct 30, 2017	Feb 6, 2018	Apr 30, 2018	Jul 31, 2018	Oct 30, 2018	Feb 6, 2019	Apr 30, 2019	Jul 30, 2019	Oct 30, 2019	Feb 6, 2020	Apr 30, 2020	Jul 30, 2020	Oct 30, 2020	Feb 4, 2021	Apr 30, 2021	Jul 30, 2021	Oct 29, 2021	Feb 4, 2022	Apr 29, 2022	Jul 29, 2022	Nov 3, 2022	Feb 2, 2023	May 4, 2023	Aug 3, 2023	Nov 3, 2023	Feb 8, 2024	May 2, 2024	Aug 1, 2024	Oct 31, 2024	Feb 13, 2025	May 5, 2025	Aug 1, 2025	Nov 3, 2025	Feb 10, 2026	May 1, 2026	Jul 31, 2026	Nov 2, 2026
EPS Estimate	-	0.01	-0.01	0.12	0.14	0.16	0.19	0.18	0.21	0.11	0.04	0.01	0.01	0.03	0.06	0.06	0.10	0.10	0.13	0.13	0.15	0.15	0.20	0.12	-0.04	0.05	0.09	0.09	0.15	0.17	0.21	0.21	0.24	0.24	0.31	0.27	0.31	0.37	0.38	0.34	0.37	0.39	0.41	0.41	0.44	0.46	0.48	0.45	0.42	0.52
EPS Actual	0.11	0.03	0.03	0.14	0.16	0.15	0.22	0.21	0.24	0.14	0.11	-0.02	0.06	0.07	0.10	0.10	0.14	0.14	0.16	0.13	0.20	0.23	0.30	0.18	0.05	0.11	0.07	0.13	0.14	0.23	0.33	0.22	0.26	0.29	0.32	0.30	0.36	0.43	0.39	0.36	0.42	0.43	0.40	0.42	0.49	0.47	0.54	0.49	0.41	-
Surprise	-	200.00%	400.00%	16.67%	14.29%	-6.25%	15.79%	16.67%	14.29%	27.27%	175.00%	-300.00%	500.00%	133.33%	66.67%	66.67%	40.00%	40.00%	23.08%	0.00%	33.33%	53.33%	50.00%	50.00%	225.00%	120.00%	-22.22%	44.44%	-6.67%	35.29%	57.14%	4.76%	8.33%	20.83%	3.23%	11.11%	16.13%	16.22%	2.63%	5.88%	13.51%	10.26%	-2.44%	2.44%	11.36%	2.17%	12.50%	8.89%	-2.38%	-
Timing	-	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	-

Key Statistics & Ratios

Market Cap1.10B

Enterprise Value1.05B

Trailing P/E47.91

Forward P/E41.15

PEG Ratio4.46

Price / Sales12.70

Price / Book10.86

EPS1.79

Book Value7.96

Revenue (TTM)86.34M

Gross Profit (TTM)65.50M

EBITDA29.18M

Profit Margin26.70%

Operating Margin31.23%

Return on Equity23.52%

Return on Assets15.56%

Shares Outstanding12.79M

Shares Float8.33M

Beta0.90

Dividend Yield0.93%

Dividend Rate0.80

Payout Ratio57.59%

Analyst Ratings

Strong Buy

Based on 2 analystsTarget 118.00

Strong Buy
1
Buy
1

Ownership Breakdown

Institutions: 62.67%
Insiders: 35.17%
Retail / Other: 2.16%

Top Institutional Holders

BlackRock Inc
967.79K7.57%
Renaissance Technologies Corp
440.71K3.45%
Copeland Capital Management, LLC
391.86K3.06%
Vanguard Capital Management, LLC
358.62K2.80%
Kayne Anderson Rudnick Investment Management LLC
349.32K2.73%
Geode Capital Management, LLC
286.56K2.24%
T. Rowe Price Investment Management,Inc.
256.70K2.01%
Nine Ten Capital Management LLC
256.56K2.01%
Dimensional Fund Advisors, Inc.
229.34K1.79%
State Street Corp
204.53K1.60%
The Goldman Sachs Group Inc
197.94K1.55%
Two Sigma Investments LLC
182.89K1.43%
Acadian Asset Management LLC
151.84K1.19%
Morgan Stanley - Brokerage Accounts
149.84K1.17%
Northern Trust Corp
123.64K0.97%
Vanguard Portfolio Management, LLC
122.42K0.96%

Top Fund Holders

Vanguard MStar Total Stk Mkt Idx Invest
264.37K2.07%
iShares Russell 2000 ETF
213.57K1.67%
Virtus KAR Small-Cap Growth I
136.77K1.07%
T. Rowe Price Small-Cap Value
114.55K0.90%

Dividends

20264×

0.20Nov 13, 20260.20Aug 14, 20260.20May 15, 20260.20Feb 23, 2026

20255×

0.50Dec 17, 20250.17Nov 14, 20250.17Aug 18, 20250.17May 20, 20250.17Feb 24, 2025

20243×

0.15Nov 15, 20240.15Aug 20, 20240.15May 17, 2024

20232×

0.63Dec 21, 20231.05Feb 10, 2023

20221×

1.00Feb 16, 2022